SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Pulmonology Consultation — Phillis Wheatley — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientPhillis Wheatley
Date of birth1753-07-01
IdentifiersMRN HR-EN015-SYN-TD; SSN (made up) 000-15-3360
Document date1773-02-23
AuthorGideon Fairbanks-Mensah, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Three months of winter wheeze, cough and breathlessness in a 19-year-old never-smoking woman, born in West Africa, who has been called frail and asthmatic since childhood but has never had lung function testing or treatment. Please confirm or refute asthma with spirometry before and after bronchodilator and FeNO, help exclude other chest disease, and advise on treatment, including preparation for a long sea journey she may make in the spring. [S]

Urgency: Within two weeks. [S]

Questions for the consultant:

History of Present Illness

Miss Wheatley, 19, is seen at the request of Dr. Hartley-Okonkwo for three months of winter wheeze, cough and breathlessness, on a background of a weak chest since childhood that was called asthma but never tested. Symptoms come on three or four days a week, with waking about twice a month, and are brought on by cold wind, kitchen and fireplace smoke, and colds. She has never smoked, has never had an inhaler, and has never needed emergency care for her breathing. She may travel by sea in the spring. She was seen alone and gave her own consent. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

8 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Budesonide-formoterol 160/4.5 mcg inhaler as needed only (GINA track 1, step 2, anti-inflammatory reliever): one inhalation whenever needed for symptoms or before exercise in the cold, no more than 12 inhalations a dayOne inhalation as neededRespiratory tract route1773-02-23 to 1773-09-21completedS

Problems

ProblemClinical statusVerificationCodeProvenance
Wheeze, cough and breathlessness this winter, for about three months: symptoms on three or four days a week, waking with cough and a tight chest about twice a month, breathless climbing the hill streets in cold air; worse with cold wind, kitchen and fireplace smoke, and colds; called a weak chest and asthma since childhood but never tested or treated. Asthma to be confirmed with spirometry before and after bronchodilator and FeNOresolvedconfirmed R06.2S — Synthetic presenting problem anchored to her documented frail, asthmatic childhood. Superseded by the diagnosis at the second visit.
Asthma, confirmed, mild persistent: variable airflow obstruction (FEV1/FVC 0.72, below the lower limit of normal, rising to 0.80 after bronchodilator; FEV1 2.24 L, 83 percent predicted, rising 330 mL or 15 percent); type 2 inflammation (FeNO 38 ppb, blood eosinophils 0.38 x10^3/uL, total IgE 165, house dust mite sensitization); tuberculosis infection test negative and chest X-ray clear. Triggers: cold air, kitchen and fireplace smoke, coldsactiveconfirmed J45.30S — Synthetic modern confirmation linked to her documented frail, asthmatic childhood and her own later descriptions of asthma.

Physical Exam

Vital signs recorded on 1773-02-23; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralSlight and composed, speaking in full sentences; oxygen saturation 98 percent
Nose and throatNasal mucosa normal; no polyps
RespiratoryFaint expiratory wheeze on forced expiration; no crackles; no clubbing
CardiovascularRegular rhythm; no murmur

Results

DateMeasureValueUnitReference rangeFlagProvenance
1773-02-23FEV1 --pre bronchodilation2.24LLower limit of normal; predicted 2.70 L; lower limit of normal 2.17 L (GLI Global race-neutral equations)NormalS
1773-02-23FEV1 --post bronchodilation2.57LLower limit of normal; predicted 2.70 L; lower limit of normal 2.17 L (GLI Global race-neutral equations)NormalS
1773-02-23FEV1 measured/predicted83%GLI Global race-neutral equationsNormalS
1773-02-23FEV1/FVC0.72{ratio}Lower limit of normal for her age (GLI Global)LowS
1773-02-23FEV1/FVC --post bronchodilation0.8{ratio}Lower limit of normal for her age (GLI Global)NormalS
1773-02-23Fractional concentration of exhaled nitric oxide38[ppb]Above 50 ppb high; 25 to 50 intermediate (ATS)HighS
1773-02-23IgE [Units/volume] in Serum or Plasma165[IU]/mL<=100 [IU]/mLHighS
1773-02-23Total score [ACT]16{score}S

Assessment

Data reviewed: Dr. Hartley-Okonkwo's intake note and results: chest X-ray clear; blood eosinophils 0.38; interferon-gamma release assay negative; urine pregnancy test negative; Asthma Control Test 15. This morning, in our laboratory, with GLI Global race-neutral equations: FEV1 2.24 L (83 percent predicted) before and 2.57 L after albuterol 400 mcg (+330 mL, +15 percent); FEV1/FVC 0.72 before, below the lower limit of normal of 0.75, and 0.80 after; FeNO 38 ppb. Total IgE 165 IU/mL; specific IgE positive to house dust mite and negative to cat and mold. [S]

Plan of Treatment